Corteva, Inc. $CTVA Shares Acquired by Staley Capital Advisers Inc.

Staley Capital Advisers Inc. increased its stake in Corteva, Inc. (NYSE:CTVAFree Report) by 1.9% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 554,074 shares of the company’s stock after purchasing an additional 10,331 shares during the quarter. Corteva accounts for 2.0% of Staley Capital Advisers Inc.’s investment portfolio, making the stock its 18th largest position. Staley Capital Advisers Inc.’s holdings in Corteva were worth $46,382,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Harris Associates L P increased its position in shares of Corteva by 168.1% in the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after buying an additional 10,675,052 shares in the last quarter. Norges Bank purchased a new stake in shares of Corteva in the 4th quarter worth about $504,001,000. Northwestern Mutual Wealth Management Co. grew its stake in Corteva by 6,527.4% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,148,212 shares of the company’s stock valued at $211,025,000 after acquiring an additional 3,100,709 shares during the last quarter. Perpetual Ltd increased its holdings in Corteva by 78,688.5% during the 4th quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock valued at $175,336,000 after acquiring an additional 2,612,459 shares in the last quarter. Finally, Amundi increased its holdings in Corteva by 125.3% during the 3rd quarter. Amundi now owns 3,415,554 shares of the company’s stock valued at $219,620,000 after acquiring an additional 1,899,248 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft increased their price target on shares of Corteva from $90.00 to $100.00 in a research report on Monday, May 11th. Wells Fargo & Company upped their target price on Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research note on Tuesday, April 21st. Weiss Ratings raised Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, May 7th. Citigroup boosted their price target on Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Finally, CICC Research upped their price objective on Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Thirteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, Corteva has a consensus rating of “Moderate Buy” and an average price target of $88.90.

View Our Latest Research Report on CTVA

Corteva Price Performance

Shares of NYSE:CTVA opened at $85.21 on Thursday. The company has a market cap of $56.99 billion, a P/E ratio of 50.12, a P/E/G ratio of 2.65 and a beta of 0.56. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $87.69. The business has a fifty day simple moving average of $80.19 and a 200-day simple moving average of $77.36.

Corteva (NYSE:CTVAGet Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The firm had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period last year, the company earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts forecast that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date was Monday, June 1st. Corteva’s payout ratio is presently 42.35%.

About Corteva

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Articles

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.